The murine anti-GD2 IgG3 mAb 3F8 plus GM-CSF proved effective for consolidating 1 st or ≥ 2nd remission of HR-NB [9, 10] and can ablate primary refractory disease in BM [11]. The gene discussed is CSF2; the disease is neuroblastoma.